Chronic Eczema Research Study (68 Weeks)

Men and women aged 18 to 75 with a clinical diagnosis of chronic atopic dermatitis (eczema) for at least two years, may qualify to participate in this study. Individuals must have moderate to severe disease, involving 10% or more of their body. To be eligible, participants must also have a recent history (within 12 months) of inadequate response to treatment with topical medications, or for whom topical treatments are otherwise medically inadvisable.

Participants will receive investigational medication via injection (either active study drug or placebo). Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last up to 68 weeks and involve about 30 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Atopic Dermatitis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more